• Adjuvants are essential for enhancing vaccine immunogenicity, especially for subunit vaccines.
• Novel adjuvants, including TLR agonists and nanoparticle-based formulations, are being developed to improve efficacy and safety.
• Understanding the mechanisms of action of adjuvants is crucial for rational vaccine design.
• Future directions include personalized adjuvants and combination strategies to address emerging infectious diseases and cancer.